The incretin changesgenerated by RYGB are likely the mainstay of this improvement in hepatic steatosisand fibrosis, as it is also in glycemic control in patients with type 2 diabetes mellitus21. The gene discussed is GCG; the disease is type 2 diabetes mellitus.